Tumorigenesis inhibitor
    2.
    发明申请
    Tumorigenesis inhibitor 失效
    肿瘤发生抑制剂

    公开(公告)号:US20060106036A1

    公开(公告)日:2006-05-18

    申请号:US10548827

    申请日:2004-03-12

    申请人: Norihisa Kato

    发明人: Norihisa Kato

    摘要: A compound having a xanthine oxidase inhibitory activity, such as 1-(3-cyano-4-neopentyloxyphenyl)pyrazole-4-carboxylic acid and the like, can be a drug for preventing cancer including colon cancer and the like, as an agent for suppressing tumorigenesis.

    摘要翻译: 具有黄嘌呤氧化酶抑制活性的化合物如1-(3-氰基-4-新戊氧基苯基)吡唑-4-羧酸等可以是用于预防癌症的药物,包括结肠癌等,作为 抑制肿瘤发生。

    Tumorigenesis inhibitor
    3.
    发明授权
    Tumorigenesis inhibitor 失效
    肿瘤发生抑制剂

    公开(公告)号:US07208514B2

    公开(公告)日:2007-04-24

    申请号:US10548827

    申请日:2004-03-12

    申请人: Norihisa Kato

    发明人: Norihisa Kato

    IPC分类号: A61K31/415

    摘要: A compound having a xanthine oxidase inhibitory activity, such as 1-(3-cyano-4-neopentyloxyphenyl)pyrazole-4-carboxylic acid and the like, can be a drug for preventing cancer including colon cancer and the like, as an agent for suppressing tumorigenesis.

    摘要翻译: 具有黄嘌呤氧化酶抑制活性的化合物如1-(3-氰基-4-新戊氧基苯基)吡唑-4-羧酸等可以是用于预防癌症的药物,包括结肠癌等,作为 抑制肿瘤发生。

    Adiponectin production enhancer
    4.
    发明授权
    Adiponectin production enhancer 有权
    脂联素生产增强剂

    公开(公告)号:US08722614B2

    公开(公告)日:2014-05-13

    申请号:US12450286

    申请日:2008-03-21

    IPC分类号: A61K38/00 A61K38/17

    摘要: The present invention relates to an adiponectin production enhancer comprising sericin as an active ingredient, and to a pharmaceutical composition and food and drink comprising sericin. These are effective in the prevention and/or amelioration of various diseases caused by reduction of blood adiponectin level such as arteriosclerosis, fatty liver and diabetes associated with obesity. The enhancer, the pharmaceutical composition and the food and drink according to the invention have excellent adiponectin production enhancing effects as well as high safety and are expected to be broadly applied to a variety of pharmaceutical preparations and food and drink.

    摘要翻译: 本发明涉及包含丝胶蛋白作为活性成分的脂联素生产增强剂,以及包含丝胶蛋白的药物组合物和食品和饮料。 这些有效预防和/或改善由血液脂联素水平降低引起的各种疾病,例如动脉硬化,脂肪肝和与肥胖相关的糖尿病。 根据本发明的增强剂,药物组合物和食品和饮料具有优异的脂连蛋白生产增强效果以及高安全性,并且预期广泛地应用于各种药物制剂和食品和饮料。

    ADIPONECTIN PRODUCTION ENHANCER
    5.
    发明申请
    ADIPONECTIN PRODUCTION ENHANCER 有权
    ADIPONECTIN生产增强剂

    公开(公告)号:US20100035810A1

    公开(公告)日:2010-02-11

    申请号:US12450286

    申请日:2008-03-21

    IPC分类号: A61K38/16 C07K14/00

    摘要: The present invention relates to an adiponectin production enhancer comprising sericin as an active ingredient, and to a pharmaceutical composition and food and drink comprising sericin. These are effective in the prevention and/or amelioration of various diseases caused by reduction of blood adiponectin level such as arteriosclerosis, fatty liver and diabetes associated with obesity. The enhancer, the pharmaceutical composition and the food and drink according to the invention have excellent adiponectin production enhancing effects as well as high safety and are expected to be broadly applied to a variety of pharmaceutical preparations and food and drink.

    摘要翻译: 本发明涉及包含丝胶蛋白作为活性成分的脂联素生产增强剂,以及包含丝胶蛋白的药物组合物和食品和饮料。 这些有效预防和/或改善由血液脂联素水平降低引起的各种疾病,例如动脉硬化,脂肪肝和与肥胖相关的糖尿病。 根据本发明的增强剂,药物组合物和食品和饮料具有优异的脂连蛋白生产增强效果以及高安全性,并且预期广泛地应用于各种药物制剂和食品和饮料。